Diabetic peripheral neuropathy
|
disease |
Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
129
|
16
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mixed anxiety and depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
146
|
13
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hyaline body
|
disease |
|
Anatomical Abnormality
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Squamous cell carcinoma of esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
2053
|
329
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Virchow's node (disorder)
|
disease |
|
Sign or Symptom
|
30
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Xeroderma pigmentosum, group G
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
20
|
31
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Xeroderma pigmentosum, group A
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
48
|
55
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Disorder of skeletal system
|
group |
Musculoskeletal Diseases
|
Disease or Syndrome
|
25
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Carcinoma, Lewis Lung
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
188
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Squamous cell carcinoma of tongue
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
462
|
2
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site
|
disease |
|
Disease or Syndrome
|
593
|
24
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Middle Cerebral Artery Occlusion
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Acquired Abnormality
|
626
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hyperhomocysteinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
246
|
45
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma of larynx
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
456
|
65
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Decreased drug resistance
|
phenotype |
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Sleep Apnea, Central
|
disease |
Respiratory Tract Diseases; Nervous System Diseases
|
Disease or Syndrome
|
122
|
17
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Endometrial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1597
|
326
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Endotoxemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
401
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Medullary carcinoma of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
330
|
71
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |